Most read article(s)

You have access
The Histamine H₃ Receptor: Structure, Pharmacology, and Function
Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa and José-Antonio Arias-Montaño

Molecular Pharmacology November 2016, 90 (5) 649-673; DOI: https://doi.org/10.1124/mol.116.104752
You have access
Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?
Martin C. Michel and Steven J. Charlton

Molecular Pharmacology April 2018, 93 (4) 259-265; DOI: https://doi.org/10.1124/mol.117.110890
You have access
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram and Paul A. Insel

Molecular Pharmacology April 2018, 93 (4) 251-258; DOI: https://doi.org/10.1124/mol.117.111062
You have access
Current Knowledge and Perspectives on Histamine H₁ and H₂ Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands
Federico Monczor and Natalia Fernandez

Molecular Pharmacology November 2016, 90 (5) 640-648; DOI: https://doi.org/10.1124/mol.116.105981
You have access
Pharmacology and Molecular Mechanisms of Clinically-Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for Endocrine-Resistant Breast Cancer Treatment
Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan

Molecular Pharmacology August 12, 2020, MOLPHARM-AR-2020-000054; DOI: https://doi.org/10.1124/molpharm.120.000054
You have access
WEAK MICROBIAL METABOLITES: A TREASURE TROVE FOR USING BIOMIMICRY TO DISCOVER AND OPTIMIZE DRUGS
Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Ryan B Sartor, Chang Kim, Maayan Levy, Sridhar Mani and Stephen J O'Keefe

Molecular Pharmacology August 6, 2020, MOLPHARM-AR-2020-000035; DOI: https://doi.org/10.1124/molpharm.120.000035
Open Access
Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4
Cristina Perpiñá-Viciano, Ali Işbilir, Aurélien Zarca, Birgit Caspar, Laura E. Kilpatrick, Stephen J. Hill, Martine J. Smit, Martin J. Lohse and Carsten Hoffmann

Molecular Pharmacology August 2020, 98 (2) 72-87; DOI: https://doi.org/10.1124/mol.119.118448
Open Access
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes
Rebecca L. Swan, Luke L.K. Poh, Ian G. Cowell and Caroline A. Austin

Molecular Pharmacology September 2020, 98 (3) 222-233; DOI: https://doi.org/10.1124/mol.119.118893
Open Access
Functional Impact of the G279S Substitution in the Adenosine A₁-Receptor (A₁R-G279S^7.44), a Mutation Associated with Parkinson’s Disease
Shahrooz Nasrollahi-Shirazi, Daniel Szöllösi, Qiong Yang, Edin Muratspahic, Ali El-Kasaby, Sonja Sucic, Thomas Stockner, Christian Nanoff and Michael Freissmuth

Molecular Pharmacology September 2020, 98 (3) 250-266; DOI: https://doi.org/10.1124/molpharm.120.000003
Open Access
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong and David M. Virshup

Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals